Skip to main content
Article
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations
LinkedIn
  • Qing Liu
  • Karl E. Peace, Georgia Southern University
Document Type
Article
Publication Date
4-28-2020
Abstract

Randomization is the foundation of any randomized controlled trial involving treatment comparisons. The major benefits of randomization in the context of clinical trials are:

  • Randomization helps mitigate various experimental biases.
  • It promotes comparability of treatment groups with respect to important known and unknown prognostic factors that may be correlated with the primary outcome.
  • It is the basis for the validity of standard statistical tests and makes the underlying assumptions of random sampling more plausible.
  • It can form the basis for statistical inference through re-randomization tests.

Citation Information
Qing Liu and Karl E. Peace. "Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations" LinkedIn (2020)
Available at: http://works.bepress.com/karl_peace/373/